UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers

Cancer research (Chicago, Ill.), 2007-04, Vol.67 (7), p.3441-3449

2007

Volltextzugriff (PDF)

Radiogenomics: a systems biology approach to understanding genetic risk factors for radiotherapy toxicity ?

Cancer letters, 2016-11, Vol.382 (1), p.95-109

2016

Volltextzugriff (PDF)

A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1

Nature genetics, 2014-08, Vol.46 (8), p.891-894

2014

Volltextzugriff (PDF)

Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy

Breast (Edinburgh), 2023-12, Vol.72, p.103578-103578, Article 103578

2023

Volltextzugriff (PDF)

Comparison of multiple gene expression platforms for measuring a bladder cancer hypoxia signature

Molecular medicine reports, 2022-08, Vol.26 (2), Article 261

2022

Volltextzugriff (PDF)

Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma

European journal of cancer (1990), 2013-01, Vol.49 (1), p.156-165

2013

Volltextzugriff (PDF)

Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter

The Journal of clinical investigation, 2010-08, Vol.120 (8), p.2842-2857

2010

Volltextzugriff (PDF)

Spectral Clustering of Microarray Data Elucidates the Roles of Microenvironment Remodeling and Immune Responses in Survival of Head and Neck Squamous Cell Carcinoma

Journal of clinical oncology, 2010-06, Vol.28 (17), p.2881-2888

2010

Volltextzugriff (PDF)

Abstract IA-021: Predicting radiotherapy outcomes: Radiogenomics and risk of radiotherapy toxicity

Clinical cancer research, 2021-04, Vol.27 (8_Supplement), p.IA-021-IA-021

West, Catharine M.L.

2021

Volltextzugriff (PDF)

No association between SNPs regulating TGF-β1 secretion and late radiotherapy toxicity to the breast: Results from the RAPPER study

Radiotherapy and oncology, 2010-10, Vol.97 (1), p.9-14

2010

Volltextzugriff (PDF)

An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3

European journal of cancer (1990), 2013-05, Vol.49 (7), p.1741-1751

2013

Volltextzugriff (PDF)

GLUT‐1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: Relationship to pimonidazole binding

International journal of cancer, 2003-03, Vol.104 (1), p.85-91

2003

Volltextzugriff (PDF)

Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosis

PLoS computational biology, 2009-11, Vol.5 (11), p.e1000571-e1000571

2009

Volltextzugriff (PDF)

Predicting tumour radiosensitivity to deliver precision radiotherapy

Nature reviews. Clinical oncology, 2023-02, Vol.20 (2), p.83-98

2023

Volltextzugriff (PDF)

Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome

JNCI : Journal of the National Cancer Institute, 2018-01, Vol.110 (1), p.14-30

2018

Volltextzugriff (PDF)

Poor Prognosis Associated With Human Papillomavirus α7 Genotypes in Cervical Carcinoma Cannot Be Explained by Intrinsic Radiosensitivity

International journal of radiation oncology, biology, physics, 2013-04, Vol.85 (5), p.e223-e229

2013

Volltextzugriff (PDF)

Hypoxia does not predict lack of benefit from adjuvant radiotherapy for patients with early stage breast cancer

British journal of cancer, 2022-05, Vol.126 (8), p.1111-1112

West, Catharine M L

2022

Volltextzugriff (PDF)

Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials

The lancet oncology, 2021-02, Vol.22 (2), p.246-255

2021

Volltextzugriff (PDF)

Identifying the Radioresponsive Genome for Genomics-Guided Radiotherapy

JNCI : Journal of the National Cancer Institute, 2021-03, Vol.113 (3), p.223-224

West, Catharine M L

2021

Volltextzugriff (PDF)

A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients

Clinical cancer research, 2017-08, Vol.23 (16), p.4761-4768

2017

Volltextzugriff (PDF)

Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinoma

British journal of cancer, 2020-02, Vol.122 (4), p.539-544

2020

Volltextzugriff (PDF)

A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer

Clinical cancer research, 2013-09, Vol.19 (17), p.4879-4888

2013

Volltextzugriff (PDF)

HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology

Cancer research (Chicago, Ill.), 2016-11, Vol.76 (22), p.6598-6606

2016

Volltextzugriff (PDF)

hsa‐miR‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer

Cancer, 2010-05, Vol.116 (9), p.2148-2158

2010

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Aktive Filter

ThemaRadiology, Nuclear Medicine & Medical Imaging

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(83)
Buchkapitel
(3)

Sprache

Englisch
(86)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Humans
(63)
Life Sciences & Biomedicine
(61)
Oncology
(48)
Female
(30)
Tumors
(28)
Male
(25)
Hypoxia
(22)
Radiation Therapy
(21)
Biological And Medical Sciences
(19)
Medical Sciences
(18)
Middle Aged
(18)
Prognosis
(18)
Radiotherapy
(16)
Gene Expression Regulation, Neoplastic
(13)
Adult
(12)
Aged
(12)
Cancer
(12)
Cancer Therapies
(11)
Gene Expression
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers

Radiogenomics: a systems biology approach to understanding genetic risk factors for radiotherapy toxicity ?

A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1

Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy

Comparison of multiple gene expression platforms for measuring a bladder cancer hypoxia signature

Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer

Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma

Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter

Spectral Clustering of Microarray Data Elucidates the Roles of Microenvironment Remodeling and Immune Responses in Survival of Head and Neck Squamous Cell Carcinoma

Abstract IA-021: Predicting radiotherapy outcomes: Radiogenomics and risk of radiotherapy toxicity

No association between SNPs regulating TGF-β1 secretion and late radiotherapy toxicity to the breast: Results from the RAPPER study

An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3

GLUT‐1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: Relationship to pimonidazole binding

Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosis

Predicting tumour radiosensitivity to deliver precision radiotherapy

Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome

Poor Prognosis Associated With Human Papillomavirus α7 Genotypes in Cervical Carcinoma Cannot Be Explained by Intrinsic Radiosensitivity

Hypoxia does not predict lack of benefit from adjuvant radiotherapy for patients with early stage breast cancer

Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials

Identifying the Radioresponsive Genome for Genomics-Guided Radiotherapy

A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients

Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinoma

A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer

HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology

hsa‐miR‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer

Aktive Filter

Suchergebnisse filtern